LOXL1 and lung carcinoma: In addition, the proliferative and anti-apoptotic activities of LOXL1-AS1 in lung cancer are mediated by the upregulation of MYBL2, a Myb-related protein, which occurs as a result of sponging miR-423–5p (38).